Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CTOR is expected to report earnings to fall 100.00% to 0 cents per share on August 18
Q2'26
Est.
$0.00
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
Q1'25
Missed
by $0.05
The last earnings report on February 13 showed earnings per share of -5 cents, missing the estimate of -1 cents. With 28.59K shares outstanding, the current market capitalization sits at 55.07M.